Your browser is no longer supported. Please, upgrade your browser.
Settings
NXTM Nxstage Medical, Inc. daily Stock Chart
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own2.00% Shs Outstand65.45M Perf Week-6.49%
Market Cap1.70B Forward P/E837.10 EPS next Y0.03 Insider Trans-11.08% Shs Float63.33M Perf Month5.19%
Income-5.80M PEG- EPS next Q-0.02 Inst Own99.80% Short Float5.34% Perf Quarter10.61%
Sales363.20M P/S4.68 EPS this Y37.60% Inst Trans0.32% Short Ratio7.94 Perf Half Y17.37%
Book/sh3.09 P/B8.40 EPS next Y137.50% ROA-1.90% Target Price30.00 Perf Year31.39%
Cash/sh0.93 P/C27.93 EPS next 5Y20.00% ROE-3.00% 52W Range13.49 - 28.36 Perf YTD-0.99%
Dividend- P/FCF629.05 EPS past 5Y11.10% ROI-7.60% 52W High-8.50% Beta0.36
Dividend %- Quick Ratio2.00 Sales past 5Y13.40% Gross Margin41.30% 52W Low92.36% ATR0.81
Employees3600 Current Ratio3.00 Sales Q/Q6.40% Oper. Margin-1.20% RSI (14)45.25 Volatility3.87% 2.87%
OptionableYes Debt/Eq0.07 EPS Q/Q90.30% Profit Margin-1.60% Rel Volume0.69 Prev Close26.00
ShortableYes LT Debt/Eq0.06 EarningsFeb 02 BMO Payout- Avg Volume425.75K Price25.95
Recom1.70 SMA20-2.85% SMA500.12% SMA20015.43% Volume292,275 Change-0.19%
Jun-28-16Upgrade Northland Capital Market Perform → Outperform
Mar-31-16Resumed Piper Jaffray Overweight $23 → $18.50
Dec-11-15Initiated Sterne Agee CRT Buy
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Jul-29-08Initiated SMH Capital Buy $8
May-14-08Reiterated JMP Securities Mkt Outperform $13 → $10
May-13-08Downgrade William Blair Outperform → Mkt Perform
Jan-19-17 01:38PM  ETFs with exposure to NxStage Medical, Inc. : January 19, 2017 -6.10%
Jan-16-17 12:00PM  NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results PR Newswire
Jan-04-17 08:39AM  Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
Jan-03-17 08:02AM  Illumina Fettered With Losses: Can It Bounce Back in 2017?
07:31AM  Masimo to Launch Advanced Monitoring Technologies in India
Jan-02-17 08:23AM  OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3
07:53AM  Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?
Dec-30-16 09:34AM  Is Baxter Poised to Counter Low Cyclophosphamide Sales?
08:54AM  CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions
08:30AM  Alere (ALR) Appeals to Reinstate Medicare Billing Privilege
08:28AM  NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite
Dec-29-16 08:03AM  LabCorp: Covance Drug Prospects Bright, Competition Rife
08:02AM  ResMed: SDB Business Faces Risks, Reimbursement a Drag
07:19AM  Nutrisystem Declares Multi-Brand Marketing Approach for '17
Dec-28-16 08:02AM  Myriad Genetics' Unit Releases Favorable Data on Vectra DA
07:36AM  Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger
Dec-27-16 08:54AM  5 Efficient Stocks to Strengthen Your Portfolio
07:49AM  Boston Scientific Down on Risks; Innovations Raise Hope
Dec-23-16 08:57AM  Qiagen Poised on Fundamentals, Expansion Plans on Track
07:32AM  Myriad Genetics: United Rheumatology Selects Vectra DA Test
Dec-22-16 07:59AM  Henry Schein Named 2016's Best Animal Healthcare Provider
Dec-21-16 08:35AM  VWR Plagued by Headwinds, Solid Fundamentals Raise Hope
07:49AM  Chemed (CHE): Roto-Rooter Solid, Reimbursement a Concern
07:18AM  Walgreens Boots and Rite Aid to Vend 865 Stores to Fred's
Dec-20-16 08:33AM  Amedisys' Unit to Buy Personal Care Provider, Home Staff
08:24AM  CVS Health (CVS) Down on Prevailing Risks, Tepid Guidance
07:47AM  Zimmer Biomet (ZBH): Spine Group Solid, Q3 Results a Drag
07:34AM  Align Technology Hits 52-Week High on Q3 & Dental Strength
Dec-19-16 08:42AM  Bruker (BRKR) Buys Active Spectrum to Boost MRI Business
08:30AM  Hill Rom Gains on Solid Q4, Buyouts & Product Launches
Dec-18-16 11:44AM  How FirstService Corp (FSV) Stacks Up Against Its Peers at Insider Monkey
Dec-16-16 09:30AM  Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime
08:35AM  CVS Health Revises View for 2016 & 2017, Declares Dividend
08:25AM  CVS Health Introduces Transform Diabetes Care Program
Dec-15-16 09:36AM  5 Potential Liquid Stocks for Yield Hungry Investors
09:01AM  Hologic Hits 52-Week High on Q4 Earnings & Solid Prospects
Dec-14-16 08:38AM  Zimmer Biomet (ZBH) Launches PrimaGen Advanced Allograft
08:24AM  Boston Scientific Acquires Neovasc to Boost Heart Business
Dec-13-16 08:44AM  Inovalon (INOV) Cuts 2016 Revenue and Earnings Guidance
07:28AM  Align Up on Balanced Growth, Expansion of Invisalign Teen
Dec-12-16 09:59AM  Genomic Health Posts Impressive Data for Oncotype DX Test
09:30AM  Zacks.com featured highlights: Diamondback Energy, Matador Resources, WellCare Health Plans, Burlington Stores and Nxstage Medical
07:52AM  Amedisys Down on Dismal Quarter, Reimbursement Headwind
07:24AM  Will Endopredict Win Myriad's (MYGN) Genomic Testing War?
Dec-09-16 09:13AM  Haemonetics Introduces Upgraded NextGen DMS 4 Software
08:44AM  Henry Schein Buys Stake in Marrodent; Spurs Polish Foothold
Dec-08-16 11:59AM  Steris Poor Q2 Disappoints, Synergy Health Raises Hope
09:13AM  Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
09:11AM  Henry Schein's Q3 Results Impress, Pricing Pressure a Drag
Dec-07-16 08:16AM  Genomic Health: Cancer Test Business Strong, Q3 Dismal
08:12AM  Medtronic Endurant II/IIs Stent Graft System Wins CE Mark
07:36AM  GNC Faces Poor Domestic Sales, Margins Still Under Pressure
Dec-06-16 07:58AM  Omnicell Unveils XT Series Automated Dispensing System
Dec-05-16 09:30AM  Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical
09:15AM  Bruker Ties Up with IPCN to Boost Preclinical Imaging Suite
09:00AM  Nxstage Medical (NXTM): An Off-the-Radar Potential Winner
08:10AM  Boston Scientific (BSX) Inks $75 Million Deal with Neovasc
03:27AM  Matson, Inc. (MATX): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-02-16 07:53AM  Medtronic Introduces CoreValve Evolut R System in Japan
07:44AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : December 2, 2016
07:40AM  Omnicell to Buy Ateb, Expand in Adherence Tools Market
07:29AM  Medtronic Stock Falls on Mixed 2Q; Positive on HeartWare Buy
Dec-01-16 08:24AM  Medtronic Partners UH to Launch Integrated Health Solutions
Nov-30-16 07:32PM  Is NxStage Medical, Inc. (NXTM) A Good Stock To Buy Right Now? at Insider Monkey
07:38AM  Medtronic's Less-Invasive HVAD Implant System Gets CE Mark
Nov-29-16 09:14AM  NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
09:03AM  Edward Lifesciences (EW) to Buy Israel's Valtech Cardio
Nov-28-16 07:58AM  Walgreen Boots: Mixed Q4, Awaits Rite Aid Deal Closure
07:38AM  Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
Nov-25-16 08:40AM  STERIS (STE): Q2 Results Disappoint, Acquisitions Bode Well
08:30AM  Can Nxstage Medical (NXTM) Stock Continue to Grow Earnings?
07:55AM  Zimmer Biomet Chosen as IUIH Preferred Orthopaedic Partner
Nov-23-16 08:11AM  Quest Diagnostics' QuestDirect Now in Colorado & Missouri
05:47AM  IDEXX: Strength in International Business & CAG Continues
Nov-22-16 10:06AM  Medtronic (MDT) Tops Q2 Earnings, Lowers FY17 Guidance -5.19%
08:19AM  Haemonetics: Medical Center of Plano Picks BloodTrack
07:53AM  Quest Diagnostics at 52-Week High on Solid Q3 & Prospects
Nov-21-16 09:09AM  Medtronic's (MDT) Heli-FX EndoAnchor System Data Positive
07:35AM  Bruker Buys OST, To Expand in Superconducting Wires Market
Nov-18-16 10:53AM  Why Nxstage Medical (NXTM) Could Be Positioned for a Surge
06:04AM  CVS Health (CVS): Sluggish Q3, Guidance Cut Pose Concerns
Nov-17-16 08:00AM  VWR Poised on Solid Fundamentals, Margin Pressure Remains
07:22AM  St. Jude Medical's MOMENTUM 3 IDE Study Results Encourage
07:16AM  Boston Scientific (BSX) Reports Positive Data on HeartLogic
07:14AM  Medtronic: FDA Okays Solitaire Device for Expanded Use
06:48AM  BioScrip: Guidance Disappoints, Home Solutions Raises Hope
Nov-16-16 04:45PM  Cardiovascular Systems at 52-Week High on Huge Prospects
09:58AM  AngioDynamics (ANGO) Announces 2.5M Secondary Offering
09:30AM  Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical
09:21AM  Zimmer Biomet (ZBH) Announces Positive Data from IDE Trial
09:15AM  TransEnterix to Present Senhance Robotic System at AAGL
08:00AM  New Data Shows Better Outcomes, Higher Quality of Life, Lower Cost of Care, and Increased Likelihood for Transplant with More Frequent Hemodialysis Using the NxStage System One PR Newswire
Nov-15-16 02:39PM  Top Stocks with Big Potential Catch-Up Moves
11:11AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
09:30AM  Zacks.com featured highlights: Nxstage Medical, Brooks Automation, KVH Industries, Tilly's and EnerSys
07:07AM  Medtronic's (MDT) MRI CRT-D Device Gains FDA Approval
Nov-14-16 08:40AM  5 Liquid Stocks to Put Your Money On
08:02AM  Medtronic Launches Orthopedic Solutions for Joint Surgery
Nov-11-16 01:04PM  NXSTAGE MEDICAL, INC. Financials
Nov-09-16 10:45AM  Tamarack Capital Managements Ariad Pharmaceuticals, Inc. (ARIA) Holding Carries It To Strong Q3 Gains at Insider Monkey
NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment engages in the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis centers in the United States and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Robert S.President, NxStage Kidney CareJan 23Option Exercise11.0315,000165,45055,564Jan 23 06:07 PM
Brown Robert S.President, NxStage Kidney CareJan 23Sale25.7415,000386,10040,564Jan 23 06:07 PM
Swan Winifred LSVP and General CounselJan 20Option Exercise11.033,00033,09014,473Jan 23 06:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 20Option Exercise14.054,30060,41523,041Jan 23 06:28 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 20Sale26.194,300112,61718,741Jan 23 06:28 PM
Swan Winifred LSVP and General CounselJan 20Sale26.193,50091,66510,973Jan 23 06:14 PM
Brown Robert S.President, NxStage Kidney CareJan 19Sale27.256,615180,26240,564Jan 23 06:07 PM
Burbank Jeffrey HChief Executive OfficerJan 18Sale27.637,500207,225867,616Jan 18 06:56 PM
Brown Robert S.President, NxStage Kidney CareJan 18Sale27.588,183225,68747,179Jan 18 06:56 PM
Brown Robert S.President, NxStage Kidney CareJan 17Sale27.7210,805299,51555,362Jan 17 04:49 PM
Burbank Jeffrey HChief Executive OfficerJan 17Sale27.527,500206,400875,116Jan 17 04:35 PM
Turk Joseph E JrPresidentJan 13Sale28.007,500210,00070,280Jan 17 04:28 PM
Turk Joseph E JrPresidentJan 11Sale27.771,00027,77077,780Jan 11 05:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 20Option Exercise14.054,30060,41523,041Dec 20 05:07 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 20Sale25.554,300109,86518,741Dec 20 05:07 PM
Swan Winifred LSVP and General CounselDec 15Option Exercise11.033,00033,09014,973Dec 16 04:07 PM
Swan Winifred LSVP and General CounselDec 15Sale25.913,50090,68511,473Dec 16 04:07 PM
Burbank Jeffrey HChief Executive OfficerDec 14Sale25.687,500192,600882,616Dec 14 06:07 PM
Burbank Jeffrey HChief Executive OfficerDec 13Sale25.427,500190,650890,116Dec 13 06:56 PM
Turk Joseph E JrPresidentDec 13Sale25.421,00025,42078,780Dec 13 06:49 PM
Turk Joseph E JrPresidentNov 28Option Exercise18.482,66949,32382,449Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 28Sale26.482,66970,67579,780Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 25Option Exercise13.029,500123,68589,280Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 25Sale25.879,500245,81079,780Nov 29 05:07 PM
Burbank Jeffrey HChief Executive OfficerNov 23Sale24.017,500180,075897,616Nov 23 06:07 PM
Swan Winifred LSVP and General CounselNov 22Option Exercise11.033,00033,09014,973Nov 22 06:00 PM
Swan Winifred LSVP and General CounselNov 22Sale25.513,00076,53011,973Nov 22 06:00 PM
Burbank Jeffrey HChief Executive OfficerNov 22Sale25.517,500191,325905,116Nov 22 05:56 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 21Option Exercise14.054,30060,41523,041Nov 21 05:00 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 21Sale26.234,300112,78918,741Nov 21 05:00 PM
Giannini Daniel ADirectorNov 21Sale25.966,449167,41663,193Nov 22 06:28 PM
Turk Joseph E JrPresidentNov 17Sale25.971,00025,97079,780Nov 18 05:00 PM
Turk Joseph E JrPresidentNov 16Sale26.2622,500590,85080,780Nov 16 06:49 PM
Mixer Jean KDirectorNov 14Option Exercise11.0011,579127,36911,579Nov 16 04:07 PM
LEWIS EARL RDirectorNov 02Option Exercise14.2333,468476,393108,786Nov 04 06:42 PM
MOORE CRAIG WDirectorSep 14Sale23.601,50035,40089,239Sep 14 05:14 PM
MOORE CRAIG WDirectorSep 12Sale23.021,50034,53090,739Sep 14 05:14 PM
Giannini Daniel ADirectorAug 04Option Exercise14.9915,272228,92779,245Aug 08 04:14 PM
LEWIS EARL RDirectorMay 25Option Exercise18.5514,000259,70089,125May 27 05:21 PM
Giannini Daniel ADirectorMay 25Option Exercise18.5514,000259,70077,780May 27 05:14 PM
MOORE CRAIG WDirectorMay 25Option Exercise18.5514,000259,700106,046May 27 05:00 PM
REID PERPERDirectorMay 25Option Exercise18.557,000129,850127,483May 27 04:42 PM
Turk Joseph E JrPresidentMay 12Sale17.891,50026,835103,280May 12 04:49 PM
Turk Joseph E JrPresidentMay 10Option Exercise9.961,05710,528105,837May 11 06:14 PM
Turk Joseph E JrPresidentMay 10Sale18.001,05719,026104,780May 11 06:14 PM
Swan Winifred LSVP and General CounselApr 14Option Exercise9.966196,16514,473Apr 15 05:35 PM
Swan Winifred LSVP and General CounselApr 14Sale14.952,50037,37511,973Apr 15 05:35 PM
Turk Joseph E JrPresidentApr 05Option Exercise9.961,0009,960109,280Apr 06 04:56 PM
Turk Joseph E JrPresidentApr 05Sale15.052,50037,625106,780Apr 06 04:56 PM
Turk Joseph E JrPresidentMar 22Sale14.342,00028,680108,280Mar 23 04:21 PM
Swan Winifred LSVP and General CounselMar 14Option Exercise9.966206,17518,234Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.696209,72817,614Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.691,88029,49713,854Apr 15 05:35 PM
Turk Joseph E JrPresidentMar 10Option Exercise9.961,0009,960112,780Mar 10 04:28 PM
Turk Joseph E JrPresidentMar 10Sale15.582,50038,950110,280Mar 10 04:28 PM
Brown Robert S.President, NxStage Kidney CareMar 03Option Exercise0.009,746069,523Mar 07 04:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 03Option Exercise0.009,746022,693Mar 07 04:07 PM
Turk Joseph E JrPresidentMar 03Option Exercise0.009,7460114,909Mar 07 04:35 PM
Swan Winifred LSVP and General CounselMar 03Option Exercise0.007,919020,358Mar 07 04:35 PM
Burbank Jeffrey HChief Executive OfficerMar 03Option Exercise0.0028,0210921,762Mar 07 04:28 PM
Turk Joseph E JrPresidentFeb 24Option Exercise2.119922,093108,155Feb 25 04:07 PM
Straube Barry MDirectorFeb 24Buy14.201,50021,3001,500Feb 25 04:07 PM
Turk Joseph E JrPresidentFeb 24Sale14.122,99242,247105,163Feb 25 04:07 PM
Swan Winifred LSVP and General CounselFeb 16Option Exercise9.966206,17514,939Feb 18 04:21 PM
Swan Winifred LSVP and General CounselFeb 16Sale14.072,50035,17512,439Feb 18 04:21 PM
LEWIS EARL RDirectorFeb 12Buy14.6321,000307,16088,145Feb 17 07:35 AM
Turk Joseph E JrPresidentFeb 09Option Exercise9.961,0009,960109,663Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 09Sale16.882,50042,200107,163Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 04Option Exercise2.119912,091109,654Feb 05 04:07 PM
Turk Joseph E JrPresidentFeb 04Sale19.6099119,424108,663Feb 05 04:07 PM